Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia

Obstetrics and Gynecology

Volumn 101, Issue 6, 2003, Pages 1266-1274

  Polliotti, Bruno M ^a,c   Fry, A Gordon ^a   Saller Jr, Devereux N ^a,b   Mooney, Robert A ^a   Cox, Christopher ^a   Miller, Richard K ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CYTOKINE; ENDOTHELIAL CELL GROWTH FACTOR; ENDOTHELIN 1; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; VASCULOTROPIN;

ADULT; ANEUPLOIDY; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FREEZING; GENETIC SCREENING; GESTATIONAL AGE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MATERNAL SERUM; MODEL; ONSET AGE; PARITY; PLACENTA DEVELOPMENT; PREDICTION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RISK; SAMPLE; SECOND TRIMESTER PREGNANCY; SENSITIVITY ANALYSIS;

EID: 0037532906     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(03)00338-7     Document Type: Article

References (25)

1. Redman C.W., Sacks G.P., Sargent I.L. Preeclampsia An excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 180:1999;499-506.
2. Roberts J.M. Preeclampsia Is there value in assessing before clinically evident disease? Obstet Gynecol. 98:2001;596-599.
3. MacKay A.P., Berg C.J., Atrash H.K. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol. 97:2001;533-538.
4. Odenhaal H.J., Pattinson R.C., du Toit R. Fetal and neonatal outcome in patients with severe preeclampsia delivered before 34 weeks. South Afr Med Health. 71:1987;555-558.
5. Meekins J.W., Pijnenborg R., Hanssens M., McFadyen I.R., van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe preeclamptic pregnancies. Br J Obstet Gynaecol. 101:1994;669-674.
6. Shore V.H., Wang T.H., Wang C.L., Torry R.J., Caudle M.R., Torry D.S. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta. 18:1997;657-665.
7. Su Y.N., Lee C.N., Cheng W.F., Shau W.Y., Chow S.N., Hsieh F.J. Decreased maternal serum placenta growth factor in early second trimester and preeclampsia. Obstet Gynecol. 97:2001;898-904.
8. Tidwell S.C., Ho H.N., Chiu W.H., Torry R.J., Torry D.S. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol. 184:2001;1267-1272.
9. Livingston J.C., Haddad B., Gorski L.A., Neblett P., Ahokas R.A., Ramsey R., et al. Placenta growth factor is not an early marker for the development of severe preeclampsia. Am J Obstet Gynecol. 184:2001;1218-1220.
10. Livingston J.C., Chin R., Haddad B., McKinney E.T., Ahokas R., Sibai B.M. Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. Am J Obstet Gynecol. 183:2000;1554-1557.
11. Sharkey A.M., Cooper J.C., Balmforth J.R., Mclaren J., Clark D.E., Charnock D.S., et al. Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by preeclampsia. Eur J Clin Invest. 26:1996;1182-1185.
12. Kupferminc M.J., Daniel Y., Englender T., Baram A., Many A., Jaffa A.J., et al. Vascular endothelial growth factor is increased in patients with preeclampsia. Am J Reprod Immunol. 38:1997;302-306.
13. Lyall F., Greer I.A., Boswell F., Fleming R. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in preeclampsia. Br J Obstet Gynaecol. 104:1997;223-228.
14. Reuvekamp A., Velsing-Aarts F., Poulina I.E., Capello J.J., Duits A.J. Selective deficit of angiogenic growth factors characterizes pregnancies complicated by preeclampsia. Br J Obstet Gynaecol. 106:1999;1019-1022.
15. Matsubara K., Ochi H., Kitagawa H., Yamanaka K., Kusanagi Y., Ito M. Concentrations of serum granulocyte-colony-stimulating factor in normal pregnancy and preeclampsia. Hypertens Pregnancy. 18:1999;95-106.
16. Cervar M., Puerstner P., Kainer F., Desoye G. Endothelin-1 stimulates the proliferation and invasion of first trimester trophoblastic cells in vitro - a possible role in the etiology of preeclampsia? J Invest Med. 44:1996;447-453.
17. Shaarawy M., Abdel-Magid A.M. Plasma endothelin-1 and mean arterial pressure in the prediction of preeclampsia. Int J Gynaecol Obstet. 68:2000;105-111.
18. Namiki A., Hirata Y., Fukazawa M., Ishikawa M., Moroi M., Aikawa J., et al. Granulocyte-colony stimulating factor stimulates immunoreactive endothelin-1 release from cultured bovine endothelial cells. Eur J Pharmacol. 227:1992;339-341.
19. Luckas M., Hawe J., Neilson J., Walkinshaw S. Second trimester serum free beta-human chorionic gonadotropin levels as a predictor of preeclampsia. Acta Obstet Gynecol Scand. 77:1998;381-384.
20. Huang S.C., Hwang J.L., Hsieh C.Y., Chen R.J., Ouyang P.C. Human chorionic gonadotropin and its subunits in preeclampsia. J Formos Med Assoc. 88:1989;132-136.
21. NIH Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 183:2000;S1-S22.
22. Diagnosis and management of preeclampsia and eclampsia. 2002;American College of Obstetricians and Gynecologists, Washington. ACOG practice bulletin no. 33.
23. Hosmer D.W., Lemeshow S. Applied logistic regression. 1989;John Wiley & Sons, New York.
24. Tjoa M.L., van Vugt J.M., Mulders M.A., Schutgens R.B., Oudejans C.B., van Wijk J. Plasma placenta growth factor levels in midtrimester pregnancies. Obstet Gynecol. 98:2001;600-607.
25. Ong C.Y., Liao A.W., Cacho A.M., Spencer K., Nicolaides K.H. First trimester maternal serum levels of placental growth factor as predictor of preeclampsia and fetal growth restriction. Obstet Gynecol. 98:2001;608-611.